Regulated expression of the tyrosine hydroxylase gene by membrane depolarization. Identification of the responsive element and possible second messengers.
Prolonged depolarization has been used as a model of adaptive changes in the expression of various proteins, such as ion channels and neurotransmitter biosynthetic enzymes, in response to increased trans-synaptic activity in the nervous system. In depolarized PC12 cells, tyrosine hydroxylase (TH) mRNA levels increased severalfold (Kilbourne, E. J., and Sabban, E. L. (1990) Mol. Brain Res. 8, 121-127). In this study, membrane depolarization caused an increase in the expression of the reporter gene chloramphenicol acetyltransferase (CAT), under transcriptional control of the 5' region of the rat TH gene. These results indicate that membrane depolarization leads to increased transcription of the TH gene. Protein kinase C inhibitors had no effect on the induction of TH mRNA by depolarization, as well as the increase in formation of CAT under control of the upstream region of the TH gene. The depolarization responsive element in the TH gene was mapped to the region containing the cAMP responsive element. This region of the TH gene also increased CAT activity in response to the calcium ionophore, ionomycin. Interestingly, combined treatment with cAMP analogs and membrane depolarization had a greater effect than either alone on TH mRNA levels, as well as on CAT activity in PC12 cells transfected with the plasmid containing the cAMP responsive element.
Kilbourne
E J
EJ
Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla 10595.
Nankova
B B
BB
Lewis
E J
EJ
McMahon
A
A
Osaka
H
H
Sabban
D B
DB
Sabban
E L
EL
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D004347:Drug Interactions; D004789:Enzyme Activation; D015971:Gene Expression Regulation, Enzymologic; D015759:Ionomycin / Q000494:pharmacology; D007976:Leupeptins / Q000494:pharmacology; D008564:Membrane Potentials; D016716:PC12 Cells; D010957:Plasmids; D011493:Protein Kinase C / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis; D012045:Regulatory Sequences, Nucleic Acid; D015290:Second Messenger Systems; D013110:Sphingosine / Q000494:pharmacology; D014158:Transcription, Genetic; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics*; D014701:Veratridine / Q000494:pharmacology
D007976:Leupeptins; D012333:RNA, Messenger; D015124:8-Bromo Cyclic Adenosine Monophosphate; D015759:Ionomycin; D014701:Veratridine; D014446:Tyrosine 3-Monooxygenase; D015500:Chloramphenicol O-Acetyltransferase; D011493:Protein Kinase C; C032854:leupeptin; D013110:Sphingosine; D002118:Calcium